Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Michael Trunk is active.

Publication


Featured researches published by Michael Trunk.


Journal of Pharmaceutical Sciences | 2010

Force control and powder dispersibility of spray dried particles for inhalation

Claudius Weiler; Marc Egen; Michael Trunk; Peter Langguth

This study aims towards a deeper understanding of the correlation between particle morphology, cohesion forces, and aerosol performance of spray dried powders for inhalation. Therefore, forces affecting cohesion and dispersion are considered and some novel contact models are introduced to explain the improved powder dispersibility of corrugated particles. Particles with different degrees of corrugation are prepared by spray drying and characterized. Powder dispersibility is measured by positioning a dry powder inhaler in front of the laser diffraction device. The particle sizes of all powders are in the range of x(50) = 2.11 +/- 0.15 microm. The ratio of mass specific surface area S(m) to volume specific surface area S(V) rises from 0.54 cm(3)/g (spherical particles) to 0.83 cm(3)/g (most corrugation). The fine particle fraction (FPF) rises significantly with increasing corrugation at 24 L/min which can be explained by a distinct difference in powder dispersibility. From theoretical models a reduction in cohesion up to 90% can be estimated for corrugated particles compared to spherical particles. Advantages in powder dispersibility can be expected for particles having a lower density and smaller radius of curvature in the contact zone. Both characteristics are given in case of corrugated particles and can be optimized to a certain degree of corrugation.


Archive | 2001

Crystalline monohydrate, method for producing the same and the use thereof in the production of a medicament

Rolf Banholzer; Peter Sieger; Christian Kulinna; Michael Trunk; Manfred Graulich; Peter Specht; Helmut Meissner; Andreas Mathes


Archive | 2003

Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions

Rolf Banholzer; Peter Sieger; Christian Kulinna; Michael Trunk; Manfred Graulich; Peter Specht; Helmut Meissner; Andreas Mathes


Archive | 2003

Salts of the CGRP antagonist BIBN4096 and inhalable powdered medicaments containing them

Michael Trunk; Claudius Weiler


Archive | 2003

Powdered medicaments containing a tiotropium salt and salmeterol xinafoate

Mareke Hartig; Michael Trunk; Rainer Soyka; Peter Sieger; Hagen Graebner; Michael Walz


Archive | 2003

Powdered medicament for inhalation comprising a tiotropium salt and salmeterol xinafoate

Hagen Graebner; Mareke Hartig-Heimel; Peter Sieger; Rainer Soyka; Michael Trunk; Michael Walz


Powder Technology | 2010

New model describing the total dispersion of dry powder agglomerates

Claudius Weiler; Markus Wolkenhauer; Michael Trunk; Peter Langguth


Archive | 2003

Crystalline micronisate, process for the manufacture thereof and use thereof for the preparation of a medicament

Helmut Bender; Hagen Graebner; Konrad Schindler; Michael Trunk; Michael Walz


Archive | 2004

Spray-dried amorphous BIBN 4096, process for preparing and the use thereof as inhalative

Michael Trunk; Claudius Weiler


Archive | 2002

Capsules containing inhalable tiotropium

Dieter Hochrainer; Karoline Bechtold-Peters; Michael Trunk; Michael Walz

Collaboration


Dive into the Michael Trunk's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge